Clinical Trial Update: Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED) [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluated a recombinant modified process Hepatitis B vaccine in older adults, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Recombinant Modified Process Hepatitis B Vaccine (Hepatitis B vaccine (recombinant))

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2009-03-31